Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Presentation

Presentation: Single Intravenous Treatment with Zinc Finger Repressor Leads to Brainwide Reduction of Prion in Nonhuman Primates and Significantly Prolongs Survival in the RML Mouse Model

Download PDF